ETERNAL's fourth newsletter reflects the project's positive progress, with pointers to two recent peer reviewed publications from within the consortium relating to greener phamaceutical manufacturing and process sustainability evaluation. You can also access thinking on the ethical balance involved when harnessing new digital technologies in pursuit of improved medicines manufacturing methods, and catch up on the output of other outreach activities in which the project has been involved in the last six months.
This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy.
By clicking Accept, you consent to our use of cookies.
